Stereochemically enriched compositions for delivery of nucleic acids

MA40241AUndetermined Publication Date: 2017-05-03SHIRE HUMAN GENETIC THERAPIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA40241
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-06-24
Filing Date
2015-06-24
Publication Date
2017-05-03
Patent Text Reader

Abstract

Provided, in part, is a composition comprising one or more chemical entities of formula i, each of which is a compound of formula (i):a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof, the composition characterized in that greater than a first threshold amount of the total amount of chemical entities of formula i in the composition: are chemical entities of formula i.A, wherein the first threshold amount is 50%; or are chemical entities of formula i.B.1, wherein the first threshold amount is 25%; or are chemical entities of formula i.B.2, wherein the first threshold amount is 25%, wherein the chemical entities of formula i.A, i.B.1, and i.B.2, are described herein, and methods of using such compositions, for example, for the delivery of a polynucleotide
Need to check novelty before this filing date? Find Prior Art